image
ADMA Biologics, Inc. ADMA
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 19.04
-5.74 %
$ 4.5 B
Market Cap
70.52
P/E
BALANCE SHEET
329 M ASSETS
-5.53%
Growth Rates
1Year -5.53%
3Years 16.60%
5Years 29.94%
7Years 45.64%
10Years 26.26%
194 M LIABILITIES
-1.28%
Growth Rates
1Year -1.28%
3Years 17.55%
5Years 22.93%
7Years 31.76%
10Years 33.98%
135 M EQUITY
-11.03%
Growth Rates
1Year -11.03%
3Years 15.28%
5Years 46.89%
7Years 64.31%
10Years 20.15%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition ADMA Biologics, Inc.
image
Current Assets 257 M
Cash & Short-Term Investments 51.4 M
Receivables 27.4 M
Other Current Assets 178 M
Non-Current Assets 72.2 M
Long-Term Investments 0
PP&E 63.5 M
Other Non-Current Assets 8.7 M
Current Liabilities 49.8 M
Accounts Payable 15.7 M
Short-Term Debt 1.04 M
Other Current Liabilities 33.1 M
Non-Current Liabilities 144 M
Long-Term Debt 140 M
Other Non-Current Liabilities 3.8 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Jun-2011 Jun-2010 Jun-2009 Jun-2008 Jun-2007
ASSETS
Cash & Cash Equivalents 51.4 86.5 51.1 55.9 26.8 22.8 43.1 9.9 10.4 17.2 26.1 12.5 8.51 K 12 K 8.7 2.6 14.7
Short Term Investments 0 0 0 0 0 0 0 5.4 6.4 4.7 2.9 0 0 0 0 0 0
Receivables 27.4 15.5 28.6 13.2 3.5 1.4 3.9 1.0 0.9 0.4 0 39.1 K 0 0 0 0 0
Inventory 172.9 163.3 124.7 81.5 53.1 18.6 12.6 5.0 3.4 1.7 1.7 1.3 0 3.4 0 0 0
Other Current Assets 5.3 10.2 4.3 6.1 5.1 3.5 3.3 0.3 0.1 0.1 0.3 0.1 59.2 K 0 0 0 0
Total Current Assets 257.0 270.4 208.7 153.7 85.8 44.5 63.2 21.7 21.3 24.1 31.1 13.9 8.51 K 12 K 8.7 2.6 14.7
PP&E 63.5 68.7 58.2 45.9 31.7 30.1 30.5 2.0 2.4 2.8 0.8 0.8 0 1.1 0 0 0
Intangible Assets 0.5 1.0 1.7 2.4 3.2 4.0 4.8 0 0 0 0 0 0 0 0 0 0
Goodwill 3.5 3.5 3.5 3.5 3.5 3.5 3.5 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0.4 0 0 0
Other Long Term Assets 4.7 4.8 4.1 2.1 2.8 6.7 6.0 27.2 K 27.2 K 0.3 0.2 (12.7) 0 0 0 0 0
Other Assets 1 0 0 0 0 0 0 0 0 0 0 0 0 (1.5) 0 0 0
Total Assets 329.2 348.5 276.3 207.7 127.1 88.9 108.0 23.7 23.7 27.2 32.0 15.6 8.51 K 12 K 8.7 2.6 14.7
LIABILITIES
Accounts Payable 15.7 13.2 12.4 11.1 9.2 5.9 5.9 2.6 2.1 1.8 2.7 1.1 0 0.8 0 0 0
Short Term Debt 1.0 0.9 0.6 0.7 0.5 60 K 0 6.1 30.3 K 13.8 K 12.7 K 11.6 K 0 0 0 0 0
Other Current Liabilities 32.9 25.1 17.2 8.0 4.3 3.5 3.4 2.4 1.9 2.3 0.9 1.4 9.82 K (0.8) 12.4 K 16.0 10.1
Total Current Liabilities 49.8 39.3 30.4 19.9 14.0 9.6 9.4 11.2 4.2 4.2 3.7 1.8 9.82 K 12.4 K 11.5 16.0 10.1
Long Term Debt 140.4 153.5 102.3 97.3 84.5 44.2 43.0 14.1 15.8 15.0 5.1 4.0 88.6 K 100 K 0 16.0 10.1
Deferred Tax Income 0 0 0 0 0 (40.5) 0 (8.0) (16.3) 83.2 K (3.8) 0 0 0 0 0 0
Other Liabilities 2.1 1.9 0.4 54.9 K 0.1 12.9 12.7 0.1 92.4 K 0.6 0.1 0.4 88.6 K 100 K 0 0 0
Total Liabilities 194.0 196.5 135.1 119.4 100.9 69.1 67.7 28.1 22.9 21.2 10.4 6.1 9.82 K 12.4 K 8.7 2.6 14.7
EQUITY
Common Stock 23 K 22.2 K 19.6 K 10.5 K 5.93 K 4.64 K 4.53 K 1.29 K 1.07 K 929 929 462 250 250 0.2 0.2 0
Retained Earnings (506.3) (478.0) (412.1) (340.5) (264.7) (216.4) (150.7) (106.9) (87.4) (69.4) (52.6) (37.1) (0.1) (0.1) 0 0 0
Other Accumulative Comprehensive Income/Loss 0 0 0 0 0 (3.4) (1.3) (2.2) (1.8) (1.3) (1.0) 0 0 (0.5) 0 0 0
Total Equity 135.2 152.0 141.2 88.2 26.2 19.8 0 0 0 0 0 0 0 0 0 0 0
Total Liabilities and Equity 329.2 348.5 276.3 207.7 127.1 88.9 108.0 23.7 23.7 27.2 32.0 15.6 8.51 K 12 K 8.7 2.6 14.7
SHARES OUTSTANDING
Common Shares Outstanding 224.0 197.9 139.6 86.1 54.3 45.2 22.9 12.2 10.4 9.3 6.5 5.3 2.5 2.5 2.5 2.5 2.5